|
|
|||
|
|
Former President Ronald Reagan is one of the estimated four million Americans who have been diagnosed with Alzheimer's Disease. For years, many drugs have been available to Alzheimer's patients offering them short-term treatments, but now a new liquid drug may bring more hope to those suffering from the disease. According to researchers, an experimental drug called Neotrofin may be the world's first Alzheimer's disease therapy drug that regenerates nerve cells in the brain, potentially bringing patients long-term effects.
NeoTherapeutics, Inc., the California based drug company that is developing Neotrofin, is launching a new clinical trial for Alzheimer's disease this April. The new study will be held in many major metropolitan areas around the country. For more information on participating in the clinical trials of Neotrofin please contact, 949-788-6700 ext. 300 or visit the Neotrofin website.
Go To Page: 1
The copyright of the article New Drug Brings Hope for Alzheimer's Disease Patients in Public Health Issues is owned by Adelle Vancil Tilton. Permission to republish New Drug Brings Hope for Alzheimer's Disease Patients in print or online must be granted by the author in writing.
For a complete listing of article comments, questions, and other discussions related to Adelle Vancil Tilton's Public Health Issues topic, please visit the Discussions page. |
||
|
|
|||